Tryptase inhibitors: a novel class of anti-inflammatory drugs

Bibliography

• SCHWARTZ LB, LEWIS RA, AUSTEN KF: Tryptase from human pulmonary mast cells. Purification and charac-terization. J. Biol. Chem. (1981) 256:11939–11943.
   PubMed Web of Science ®Google Scholar
• CRAIG SS, SCHWARTZ LB: Tryptase and chymase, markers of distinct types of human mast cells. Immunol. Res. (1989) 8:130–148.
   PubMed Web of Science ®Google Scholar
• IRANI AA, SCHECHTER NM, CRAIG SS, DEBLOIS G, SCHWARTZ LB: Two types of human mast cells that have distinct neutral protease compositions. Proc. Natl. Acad. Sci. USA (1986) 83:4464–4468.
   PubMed Web of Science ®Google Scholar
• SCHWARTZ LB, IRANI AA, ROLLER K, CASTELLS MC, SCHECHTER NM: Quantitation of histamine, tryptase, and chymase in dispersed human T and TC mast cells. Immunol (1987) 138:2611–2615.
   Web of Science ®Google Scholar
• SINHA U, SINHA S, JANOFF A: Characterization of sheep alpha-1-antiproteinase inhibitor. Important differ-ences from the human protein. Am. Rev. Respk. Dis. (1988) 137:558–563.
   PubMedGoogle Scholar
• CASTELLS MC, IRANI AA, SCHWARTZ LB: Evaluation of human peripheral blood leukocytes for mast cell tryp-tase. Immunol. (1987) 138:2184–2189.
   Web of Science ®Google Scholar
• SCHWARTZ LB, BRADFORD TR: Regulation of tryptase from human lung mast cells by heparin: stabilization of the active tett-amen./ Biol. Chem. (1986) 261:7372–7379.
   PubMed Web of Science ®Google Scholar
• SCHWARTZ LB, BRADFORD TR, LEE DC, CHLEBOWSKI JF: Immunologic and physicochemical evidence for con-formational changes occurring on conversion of hu-man mast cell tryptase from active tetramer to inactive monomer: production of monoclonal antibodies r ecog-nizing active tryptase. j Immunol. (1990) 144:2304–2311.
   PubMed Web of Science ®Google Scholar
• WENZEL S, IRANI AM, SANDERS JM, BRADFORD TR, SCHWARTZ LB: Immunoassay of tryptase from human mast cells. J. Immunol Methods (1986) 86:139–142.
   PubMed Web of Science ®Google Scholar
• ENANDER I, MATSSON P, NYSTRAND J et al: A new radioimmunoassay for human mast cell tryptase using monoclonal antibodies. J. Immunol Methods (1991) 138:39–46.
   PubMed Web of Science ®Google Scholar
• SCHWARTZ LB, METCALFE DD, MILLER JS, EARL H, SULLI-VAN T: Tryptase levels as an indicator of mast-cell activation in systemic anaphylaxis and mastocytosis. NewEngl. J. Med. (1987) 316:1622–1626.
   PubMed Web of Science ®Google Scholar
• WENZEL SE, FOWLER AA III, SCHWARTZ LB: Activation of pulmonary mast cells by bronchoalveolar allergen challenge: in vivo release of histamine and tryptase in at opic subjects with and without asthma. Am. Rev. Respir. Dis. (1988) 137:1002–1008.
   PubMed Web of Science ®Google Scholar
• BUTRUS SI, OCHSNER KI, ABELSON MB, SCHWARTZ LB: The level of tryptase in human tears: an indicator of activation of conjunctival mast cells. Ophthalmology (1990) 97:1678–1683.
   PubMed Web of Science ®Google Scholar
• ROZNIECKI JJ, HAUSER SL, STEIN M, LINCOLN R, THEO-HARIDES TC: Elevated mast cell tryptase in cerebrospi-nal fluid of multiple sclerosis patients. Ann. Neurol (1995) 37:63–66.
   PubMed Web of Science ®Google Scholar
• MILLER JS, WESTIN EH, SCHWARTZ LB: Cloning and characterization of complementary DNA for human tryptase. J. Clin. Invest (1989) 84:1188–1195.
   PubMed Web of Science ®Google Scholar
• MILLER JS, MOXLEY G, SCHWARTZ LB: Cloning and char-acterization of a second complementary DNA for hu-man tryptase. j Clin. Invest (1989) 86:864–870.
   Web of Science ®Google Scholar
• VANDERSLICE PS, BALLINGER SM, TAM EK et al.: Human mast cell tryptase: multiple cDNAs and genes reveal a multigene serine protease family. Proc. Natl. Acad. Sci. USA (1990) 87:3811–3815.
   PubMed Web of Science ®Google Scholar
• XIA HZ, KEPLEY CL, SAKAI K et al.: Quantitation of tryptase, chymase, FceRla, and FceRlgamma mRNAs in human mast cells and basophils by competitive reverse transcription-polymerase chain reaction. J. Immunol. (1995) 154:5472–5480.
   PubMed Web of Science ®Google Scholar
• SCHWARTZ LB, SAKAI K, BRADFORD TR et al: The a form of human tryptase is the predominant type present in blood at baseline in normal subjects and is elevated in those with systemic mastocytosis. j Clin. Invest. (1995) 96:2702–2710.
   PubMed Web of Science ®Google Scholar
• SCHWARTZ LB, BRADFORD TR, LITTMAN BH, WINTROUB:The fibrinogenolytic activity of purified tryptase from human lung mast cells. J. ImmunoL (1985) 135:2762–2767.
   PubMed Web of Science ®Google Scholar
• GRUBER BL, MARCHESE MJ, SUZUKI K et al.: Synovial procollagenase activation by human mast cell tryptase dependence upon matrix metalloproteinase 3 activa- tion. J. Clin. Invest (1989) 84:1657–1662.
   PubMed Web of Science ®Google Scholar
• GRUBER BL, SCHWARTZ LB, RAMAMURTHY NS et al.: Activation of latent rheumatoid syno vi al colla ge na se by human mast cell tryptase. J. Immunol. (1988) 140:3936–3942.
   PubMed Web of Science ®Google Scholar
• LOHI J, HARVIMA I, KESKI-OJA J: Pericellular substrates of human mast cell tryptase: 72,000 dalton gelatinase and fibronectin. J. Cell. Biochem. (1992) 50:337–349.
   PubMed Web of Science ®Google Scholar
• KIELTY CM, LEES M, SHUTTLEWORTH CA, WOOLLEY D:Catabolism of intact type VI collagen microfibrils: sus- ceptibility to degradation by serine proteinases. Bio-chem. Biophys Res. Commun. (1993) 191:1230–1236.
   PubMed Web of Science ®Google Scholar
• STACK MS, JOHNSON DA: Human mast cell tryptase activates single-chain urinary-type plasminogen activa- tor. J. Biol. Chem. (1994) 269:9416–9419.
   PubMed Web of Science ®Google Scholar
• CHURCH MK, LOWMAN MA, REES PH, BENYON RC: Ple- nary lecture: mast cells, neuropeptides and inflamma- tion. Agents Actions (1989) 27:8–16.
   PubMedGoogle Scholar
• TAM EK, CAUGHEY, GH: Degradation of airway neuropeptides by human lung tryptase . Am. J. Respir. Cell Mol. Biol. (1990) 3:27–32.
   PubMed Web of Science ®Google Scholar
• WALLS AF, BRAIN SD, DESAI A et al.: Human mast cell tryptase attenuates the vasodilator activity of calcitonin gene-related peptide. Biochem. Pharmacol. (1992) 43:1243–1248.
   PubMed Web of Science ®Google Scholar
• SCHWARTZ LB, KAWAHARA MS, HUGLI TE eta].: Genera- tion of C3a anaphylatmdn from human C3 by human mast cell tryptase. j Immunol (1983) 130:1891–1895.
   Google Scholar
• MATER M, SPRAGG J, SCHWARTZ LB: Inactivation of human high molecular weight kininogen by mast cell tryptase. j Immunol. (1983) 130:2352–2356.
   PubMed Web of Science ®Google Scholar
• SCHWARTZ LB, BRADFORD TR, GRIFFIN JH: The effect of tryptase from human mast cells on human prekallik- rein. Biochem. Biophys. Res. Commun. (1985) 129:76–81.
   PubMed Web of Science ®Google Scholar
• ALTER SC, YATES P, MARGOLIUS HS, SCHWARTZ LB: Tryptase and kinin generation: tryptase from human mast cells does not activate human urinary prokallik- rein. Int. Archs. Allergy Appl. Immunol (1987) 83:321–324.
   PubMedGoogle Scholar
• PROUD D, SIEKIERSKI ES, BAILEY GS: Identification of human lung mast cell kininogenase as tryptase and relevance of tryptase kininogenase activity. Biochem. Pharmacol (1988) 37:1473–1480.
   PubMed Web of Science ®Google Scholar
• WALLS AF, BENNETT AR, SUEIRAS-DIAS J, OLSSON H: The kininogenase activity of human mast cell tryptase. Biochem. Soc. Trans. (1992) 22:260S.
   Google Scholar
• IMAMURA T, DUBIN A, MOORE W, TANAKA R, TRAVIS J: Induction of vascular permeability enhancement by human tryptase: dependence on activation of prekal-likrein and direct release of bradykinin from kinino- gens. Lab. Invest (1996) 74:861–870.
   PubMed Web of Science ®Google Scholar
• ABRAHAM WM, BURCH RM, FARMER SG et al: A bradykinin antagonist modifies allergen-induced me-diator release and late bronchial responses in sheep. Am. Rev. Respir. as. (1991) 143:787–796.
   PubMed Web of Science ®Google Scholar
• SEKIZAWA K, CAUGHEY GH, LAZARUS SC, GOLD WM, NADEL JA: Mast cell tryptase causes airway smooth muscle hyperresponsiveness in dogs. J. Clin. Invest (1989) 83:175–179.
   PubMed Web of Science ®Google Scholar
• RUOSS SJ, HARTMANN T, CAUGHEY GH: Mast cell tryp- tase is a mitogen for cultured fibroblasts. J. Clin. Invest (1991) 88:493–499.
   PubMed Web of Science ®Google Scholar
• HARTMANN T, RUOSS SJ, RAYMOND WW, SEUWEN K, CAUGHEY GH: Human tryptase as a potent, cell-specific mitogen: role of signaling pathways in synergistic re- sponses. Am. J. Physiol (1992) 262:L528–L534.
   PubMed Web of Science ®Google Scholar
• CAIRNS JA, WALLS AF: Mast cell tryptase is a mitogen for epithelial cells: stimulation of IL-8 production and ICAM-1 expression. J. Immunol (1996) 156:275–283.
   PubMed Web of Science ®Google Scholar
• BROWN pc, TYLER CL, JONES CA et al.: Tryptase, the dominant secretory granular protein in human mast cells, is a potent mitogen for cultured dog tracheal smooth muscle cells. Am. J. Revir. Cell Mol Biol. (1995) 13:227–236.
   PubMed Web of Science ®Google Scholar
• HARTMANN T, RUOSS SJ, CAUGHEY GH: Modulation of thrombin and thrombin receptor peptide mit ogenicity by human lung mast cell tryptase. Am. J. Physiol. (1994) 2671113–L119.
   Google Scholar
• NYSTEDT S, EMILSSON K, WAHLESTEDT C, SUNDELIN J: Molecular cloning of a potential proteinase activated receptor. Proc. Nail. Acad. Sci USA (1994) 91:9208–9212.
   PubMed Web of Science ®Google Scholar
• MOLINO M, BARNATHAN ES, NUMEROF R et al.: Interac- tions of mast cell tryptase with thrombin receptors and PAR-2. J. Biol. Chem. (1997) 272:4043–4049.
   PubMed Web of Science ®Google Scholar
• HE S, WALLS AF: Mast cell activation induced by human mast cell tryptase. Am. J. Resp. Grit. Care Med. (1996) 153:A399.
   Google Scholar
• JUNG K-S, SHUTE JK, CAIRNS JA eta].: Human mast cell tryptase: a mediator of eosinophil chemotaxis. Am. J. Resp. Grit. Care Med. (1995) 151:A530.
   Google Scholar
• NUMEROF R, MOORE W, TANAKA R: Activation of human eosinophils, but not neutrophils, in response to mast cell tryptase. Am. J Resp. Grit Care Med. (1996) 153:A202.
   Google Scholar
• MOLINARI JF, SCURI M, MOORE WR etal: Inhale d trypta se causes bronchoconstriction in sheep via histamine release. Am. J. Resp. Grit. Care Med. (1996) 154:649–653.
   PubMed Web of Science ®Google Scholar
• MOLINARI JF, MOORE WR, CLARK J et al.: Role of tryptase in immediate cutaneous responses in allergic sheep. J. Appl. Physiol. (1995) 79:1966–1970.
   PubMed Web of Science ®Google Scholar
• CLARK JM, ABRAHAM WM, FISHMAN CE eta].: Tryptase inhibitors block allergen-induced airway and inflam- matory responses in allergic sheep. Am. j Resp. Grit. Care Med. (1995) 152:2076–2083.
   Google Scholar
• MOORE VVR, ELROD KC, JOHNSON CR, TANAKA RD: The chemical mechanism of human tryptase inhibition by the dipeptide, APC-366. FASEB J (1995) 9:A1344.
   Web of Science ®Google Scholar
• RADIKA K, ELROD KC, KUO EY etal: Inhibition of human tryptase by APC-366 and its analogs: structure-activity relationships. FASEB j (1996) 10:A1404.
   Google Scholar
• ABRAHAM WM, DELEHUNT JC, YERGER L, MARCHETTE B: Characterization of a late phase pulmonary response following antigen challenge in allergic sheep. Am. Rev. Respir. Dis. (1983) 128:839–844.
   PubMed Web of Science ®Google Scholar
• ABRAHAM WM, SIELCZAK MW, AHMED A et al.: at-inte-grins mediate antigen-induced late bronchial re-sponses and prolonged airway hyperresp onsiveness in sheep. J. Clin. Invest. (1994) 93:776–787.
   PubMed Web of Science ®Google Scholar
• BARNES PJ: Inhaled glucocorticoids for thma. New Engl. J. Med. (1995) 332:868–875.
   PubMed Web of Science ®Google Scholar
• MICAN JM, METCALFE D: Arthritis and mast cell activa-tion. J. Allergy Gin. Immunol. (1990) 86:677–683.
   PubMed Web of Science ®Google Scholar
• DELEURAN B, KRISTENSEN M, LARSEN CG et al.: Increased tryptase levels in suction-blister fluid from patients with urticaria. Br. J. Dermatol (1991) 125:14–17.
   PubMed Web of Science ®Google Scholar
• IRANI AM, SAMPSON H, SCHWARTZ LB: Mast cells in atopic dermatitis. Allergy (1989) 44:31–34.
   PubMed Web of Science ®Google Scholar
• WINTROUB B, MIHM M, GOETZL E, SOTER N, AUSTEN K: Morphologic and functional evidence for the release of mast cell products in bullous pemphigoid. New Engl. J. Med. (1978) 298:417–421.
   PubMed Web of Science ®Google Scholar
• SCHUBERT C, CHRISTOPHERS E: Mast cells and macro-phages in early relapsing psoriasis. Arch. Dermatol Res. (1985) 277:352–358.
   PubMed Web of Science ®Google Scholar
• HAWKINS RA, CLAMAN HN, CLARK RA, STEIGERWALD JC: Increased dermal mast cell populations in progressive systemic sclerosis: a link in chronic fibrosis? Ann. Intern. Med. (1985) 102:182–186.
   Web of Science ®Google Scholar